Peter Arbor

Real-world evidence (RWE) from electronic health records is transforming cancer drug evaluation, with the FDA increasingly accepting RWE to supplement or replace randomized trial data in certain settings. Flatiron Health has been a leader in building the infrastructure for EHR-based oncology real-world data and in demonstrating the validity of RWE approaches for regulatory purposes in oncology — enabling faster access to new treatments.